LeMaitre Vascular

Burlington, United States Founded: 1983 • Age: 43 yrs
Devices for peripheral vascular disease treatment are developed and marketed.
Request Access

About LeMaitre Vascular

LeMaitre Vascular is a company based in Burlington (United States) founded in 1983.. LeMaitre Vascular has raised $5.83 million across 7 funding rounds. The company has 664 employees as of December 31, 2024. LeMaitre Vascular has completed 5 acquisitions, including Artegraft, Duke Vascular and Inavein. LeMaitre Vascular offers products and services including AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®. LeMaitre Vascular operates in a competitive market with competitors including Avinger, Pathway Medical Technologies, Intact Vascular, Okami Medical and Cagent Vascular, among others.

  • Headquarter Burlington, United States
  • Employees 664 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lemaitre Vascular, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $219.86 M
    13.63
    as on Dec 31, 2024
  • Net Profit
    $44.04 M
    46.28
    as on Dec 31, 2024
  • EBITDA
    $62 M
    33.05
    as on Dec 31, 2024
  • Total Equity Funding
    $5.83 M (USD)

    in 7 rounds

  • Latest Funding Round
    $25 K (USD), Series A

    Sep 01, 2005

  • Investors
  • Employee Count
    664

    as on Dec 31, 2024

  • Investments & Acquisitions
    Artegraft

    & 4 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of LeMaitre Vascular

LeMaitre Vascular is a publicly listed company on the NASDAQ with ticker symbol LMAT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: LMAT . Sector: Health technology · USA

Products & Services of LeMaitre Vascular

LeMaitre Vascular offers a comprehensive portfolio of products and services, including AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Polyester grafts for aortic repair and vascular procedures

Allografts for cardiac and vascular reconstruction

Catheters used for vascular occlusion in surgeries

Devices for secure vascular closure during procedures

People of LeMaitre Vascular
Headcount 200-500
Employee Profiles 104
Employee Profiles
People
Sharon Bianco
Senior Regulatory Affairs Specialist - Permanent Role
People
David B. Roberts
President & Board Director
People
Ryan H. Connelly
VP, Research & Development
People
Roli Kumar-Choudhury
Vice President Of Quality Affairs

Unlock access to complete

Funding Insights of LeMaitre Vascular

LeMaitre Vascular has successfully raised a total of $5.83M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $25 thousand completed in September 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series A — $25,000
  • First Round

    (01 Jun 2002)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2005 Amount Series A - LeMaitre Vascular Valuation

investors

Aug, 2005 Amount Series A - LeMaitre Vascular Valuation

investors

Feb, 2005 Amount Series A - LeMaitre Vascular Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by LeMaitre Vascular

LeMaitre Vascular has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Artegraft, Duke Vascular and Inavein. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Regenerative medicines from human tissues are developed for multiple diseases.
2013
Rupture management kits and tracker delivery systems are manufactured.
2008
Varicose and spider vein treatment devices are developed and marketed.
2007
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - LeMaitre Vascular

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lemaitre Vascular Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of LeMaitre Vascular

LeMaitre Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, Pathway Medical Technologies, Intact Vascular, Okami Medical and Cagent Vascular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of image-guided catheter-based products for peripheral artery disease
domain founded_year HQ Location
Smart devices are provided to clear peripheral arterial blockages.
domain founded_year HQ Location
Implants for repairing arteries after angioplasty are developed.
domain founded_year HQ Location
Innovative medical devices for peripheral vessel treatment are developed.
domain founded_year HQ Location
Devices for removing vascular blockages are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lemaitre Vascular

Frequently Asked Questions about LeMaitre Vascular

When was LeMaitre Vascular founded?

LeMaitre Vascular was founded in 1983 and raised its 1st funding round 19 years after it was founded.

Where is LeMaitre Vascular located?

LeMaitre Vascular is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.

Is LeMaitre Vascular a funded company?

LeMaitre Vascular is a funded company, having raised a total of $5.83M across 7 funding rounds to date. The company's 1st funding round was a Series A of $2.1M, raised on Jun 01, 2002.

How many employees does LeMaitre Vascular have?

As of Dec 31, 2024, the latest employee count at LeMaitre Vascular is 664.

What is the annual revenue of LeMaitre Vascular?

Annual revenue of LeMaitre Vascular is $219.86M as on Dec 31, 2024.

What does LeMaitre Vascular do?

LeMaitre Vascular was founded in 1983 and focuses on the development, manufacturing, and marketing of medical devices and implants for peripheral vascular disease. Products such as embolectomy catheters, occlusion catheters, perfusion catheters, and carotid shunts are produced. Operations extend worldwide from the headquarters in Burlington, United States. The company, formerly known as Vascutech, underwent a name change in April 2001.

Who are the top competitors of LeMaitre Vascular?

LeMaitre Vascular's top competitors include Avinger, Okami Medical and Cagent Vascular.

What products or services does LeMaitre Vascular offer?

LeMaitre Vascular offers AlboGraft®, RestoreFlow®, Pruitt®, and AnastoClip®.

Is LeMaitre Vascular publicly traded?

Yes, LeMaitre Vascular is publicly traded on NASDAQ under the ticker symbol LMAT.

How many acquisitions has LeMaitre Vascular made?

LeMaitre Vascular has made 5 acquisitions, including Artegraft, Duke Vascular, and Inavein.

What is LeMaitre Vascular's ticker symbol?

The ticker symbol of LeMaitre Vascular is LMAT on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available